Above all, our research provided further evidence that inhibition of platelet activation suppressed reactive enteric glia related to CD40L–CD40–TRAF6 signaling pathway and affected the release of GSNO and inflammatory factors TNF-α and IL-1β of enteric glial cells, thereby mitigating intestinal barrier dysfunction during sepsis. The gene discussed is CD40LG; the disease is Sepsis.